TriSalus Life Sciences, Inc. — Director's Dealing 2025

May 21, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TriSalus Life Sciences, Inc. (TLSI)
CIK: 0001826667
Period of Report: 2025-05-19

Reporting Person: Murphy Sean (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-19	Common Stock	A	44884	$5.18	Acquired	123989	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	357535	Indirect
Common Stock	197732	Indirect

Footnotes

F1: The granted RSUs vest immediately.

F2: The Reporting Person's spouse has voting and investment discretion with respect to the shares held directly by Murphy Family Trust 2012 and thus the Reporting Person may be deemed to have beneficial ownership of the shares held directly by Murphy Family Trust 2012.